Centro de Salud Mas Font
- Address
- lock Available on a paid plan
Centro de Salud Mas Font - Respiratory Research Center
Centro de Salud Mas Font is a clinical research facility dedicated to advancing treatment strategies for chronic respiratory conditions. The center specializes in evaluating innovative therapeutic approaches for patients with complex pulmonary diseases, with particular emphasis on optimizing medication delivery systems and combination therapies.
- Chronic Obstructive Pulmonary Disease (COPD) management and treatment optimization
- Cardiopulmonary outcomes assessment in respiratory disease populations
- Comparison of triple therapy versus dual bronchodilator regimens using metered-dose inhalers
The center's research portfolio focuses on evaluating combination triple therapy approaches including budesonide, glycopyrronium, and formoterol fumarate delivered via MDI technology. Their clinical investigations examine how different therapeutic combinations impact severe cardiopulmonary outcomes in COPD patients, contributing valuable evidence to guide treatment decisions for this prevalent and progressive respiratory condition.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro de Salud Mas Font
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| European Clinical Research Alliance on Infectious Diseases – primary care adaptive platform trial for pandemics and epidemics (ECRAID-Prime) | Universitair Medisch Centrum Utrecht | Phase IV | Not Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Budesonide | 1 | Unknown | 2024-07-04 | 2024-07-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.